Skip to main content

Advertisement

SpringerLink
Log in

Distinct clinico-immunological profile of patients infected with human papilloma virus genotypes 6 and 11

  • Short Communication
  • Published:
VirusDisease Aims and scope Submit manuscript

Abstract

Anogenital warts are primarily caused by Human Papillomavirus (HPV) type 6 and 11, which belong to the taxonomic family Papillomaviridae, genus alpha-papillomavirus and species 10. The presentation of the warts is varied and most of the patients have high recurrence rate of wart lesions. Studies had shown that an effective cellular immune response is required for the control of HPV infection. Here, we report distinct clinico-immunological profile of two patients presenting with venereal warts caused by HPV genotypes 6 and 11. The Case 1 manifested greater number of verrucous warts and case 2 had fewer subtle lesions. Further, evaluation of HPV antigen-specific cellular immune response revealed a robust T cell response against HPV6 peptide and a weak response against HPV11 in case 1. Interestingly, HPV genotyping revealed type 6 in case 1 with greater severity of infection and robust immune response against HPV6 peptide. In contrast, case 2 presented with milder infection and weak immune response and was positive for genotype 11. More extensive study with larger cohorts will strengthen our observation and could be relevant for designing immunotherapeutic adjunct strategies along with the standard treatment for rapid clearance of HPV infections in these patients. This communication reports immune status of two patients with venereal warts and their correlation with clinical presentation and the genotyping.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

References

  1. Lacey CJ, Lowndes CM, Shah KV. Chapter 4: burden and management of non-cancerous HPV related conditions: HPV-6/11 disease. Vaccine. 2006;24(Suppl 3):S35–41. doi:10.1016/j.vaccine.06.015.

    Article  Google Scholar 

  2. Garland SM, Steben M, Sings HL, James M, Lu S, Railkar R, et al. Natural history of genital warts:analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine. J Infect Dis. 2009;199:805–14. doi:10.1086/597071.

    Article  PubMed  Google Scholar 

  3. Chan PK, Luk AC, Luk TN, Lee KF, Cheung JL, Ho KM, et al. Distribution of Human Papillomavirus types in anogenital warts of men. J Clin Virol. 2009;44(2):111–4. doi:10.1016/j.jcv.2008.11.001.

    Article  CAS  PubMed  Google Scholar 

  4. Schiffman M, Castle PE, Jeronimo J, Rodrigues AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet. 2007;370(9590):890–907. doi:10.1016/S0140-6736(07)61416-0.

    Article  CAS  PubMed  Google Scholar 

  5. Frenkl TL, Potts J. Sexually transmitted diseases. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh Urology. 9th ed. Philadelphia: Saunders Elsevier; 2007. p. 371–85.

    Google Scholar 

  6. Oriel JD. Natural history of genital warts. Br J Vener Dis. 1971;47(1):1–13.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. Mougin C, et al. Epidemiology of genital human papilloma Virus infections. Recent knowledge. Presse Med. 2001;30(20):1017–23.

    CAS  PubMed  Google Scholar 

  8. De Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004;324(1):17–27.

    Article  PubMed  Google Scholar 

  9. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12–9.

    Article  CAS  PubMed  Google Scholar 

  10. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer- burden and assessment of causality. J Natl Cancer Inst Monogr. 2003;31:3–13.

    Article  Google Scholar 

  11. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of human papillomavirus infection in young women. N Engl J Med. 1998;338(7):423–8.

    Article  CAS  PubMed  Google Scholar 

  12. Moscicki AB, Shiboski S, Broering J, et al. The natural history of Human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr. 1998;132(2):277–84.

    Article  CAS  PubMed  Google Scholar 

  13. Giuliano AR, Harris R, Sedjo RL, et al. Incidence, prevalence and clearance of type specific Human papillomavirus infection: the young women’s health study. J Infect Dis. 2002;186(4):462–9.

    Article  PubMed  Google Scholar 

  14. De la Fuente SG, Ludwig KA, Mantyh CR. Preoperative immune status determines anal condyloma recurrence after surgical excision. Dis Colon Rectum. 2003;46:376. doi:10.1007/s10350-004-6557-6.

    Google Scholar 

  15. Shukla S, Mahata S, Shishodia G, Pande S, Verma G, Hedau S, Bhambhani S, Kumari A, Batra S, Basir SF, Das BC, Bharti AC. Physical state & copy number of high risk human papillomavirus type 16 DNA in progression of cervical cancer. Indian J Med Res. 2014;139(4):531–43.

    CAS  PubMed  PubMed Central  Google Scholar 

  16. Quality, Safety and Standards (QSS) team. Human papillomavirus laboratory manual. 1st ed. Geneva: World Health Organization; 2010. p. 35–63.

    Google Scholar 

  17. Horn TD, Johnson SM, Helm RM, Roberson PK. Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigen: a single Blinded, randomized and controlled trial. Arch Dermatol. 2005;141:589–94.

    Article  PubMed  Google Scholar 

  18. Saoji V, Lade NR, Gadegon R, Bhat A. Immunotherapy using purified proteinderivative in the treatment of warts: an open uncontrolled trial. Indian J Dermatol Venereol Leprol. 2016;82:42–6.

    Article  PubMed  Google Scholar 

  19. Yang J, Pu YG, Zeng ZM, Yu ZJ, Huang N, Deng QW. Interferon for the treatment of genital warts: a systematic review. BMC Infect Dis. 2009;9:156.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

The authors hereby acknowledge the valuable contribution of Junior and Senior Residents of Department of Dermatology, Dr. Ram Manohar Lohia Hospital, New Delhi for patient recruitment, Dr. Alok Chandra Bharti and Mohit Jadli, Molecular Oncology Laboratory, Department of Zoology, University of Delhi & Division of Molecular Oncology, National Institute of Cancer Prevention and Research (ICMR), Noida, Uttar Pradesh, India, for genotyping and Mr. N.P. Singh, Lab. technician, Abhinav Saurabh, Prabin, SRF, Department of Transplant Immunology and Immunogenetics, AIIMS for their laboratory support.

Author information

Authors and Affiliations

  1. Room No. 311, Indian Council of Medical Research, V. Ramalingaswami Bhawan, New Delhi, 110029, India

    Manjula Singh

  2. Room NO. 92B, Department of Transplant Immunology and Immunogenetics, All India Institute of Medical Sciences, Ansari Nagar, New Delhi, 110029, India

    Deepshi Thakral & Dipendra Kumar Mitra

  3. Department of Dermatology, Venereology and Leprosy, Dr. RML Hospital, Baba Kharak Singh Marg, New Delhi, 110001, India

    Hemanta Kumar Kar & Prafulla Kumar Sharma

  4. Amity Institute of Virology and Immunology, Amity University, Noida, Uttra Pradesh, 201313, India

    Narayan Rishi

Authors
  1. Manjula Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Deepshi Thakral
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hemanta Kumar Kar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Narayan Rishi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Prafulla Kumar Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Dipendra Kumar Mitra
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Dipendra Kumar Mitra.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Singh, M., Thakral, D., Kar, H.K. et al. Distinct clinico-immunological profile of patients infected with human papilloma virus genotypes 6 and 11. VirusDis. 28, 200–204 (2017). https://doi.org/10.1007/s13337-017-0370-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13337-017-0370-z

Keywords

Search

Navigation